In April 2025, Johnson & Johnson announced new Phase 2b SunRISe-1 data for TAR-200, an intravesical gemcitabine-releasing system, at the AUA 2025 Annual Meeting
This advanced dual-action formula targets hair follicles at the root level, creating the optimal conditions for stronger, denser hair growth
The isolated fraction induced delta-wave (slow-wave) sleep when injected into recipient animals giving the peptide its name and initiated one of the most distinctive research trajectories in neuropeptide biology: a compound with a clearly demonstrated biological name-property, an exceptionally wide pharmacological activity profile, and nearly five decades later a receptor that remains formally uncharacterised
This page will provide you with detailed information about AOD-9604, its benefits, mechanisms, and how our personalized therapy can enhance your weight management efforts
Skin loses its cellular defense against collagen breakdown